Mayo Clinic gastroenterologist and celiac disease expert Joseph Murray, M.D., discusses recent research, published in the American Journal of Gastroenterology, which examines the identification of a gluten-degrading enzyme as a potential novel treatment for celiac disease.
Researchers examined bacteria in stool samples of healthy people, and characterized enzymes made by bacteria that adapted to eat or degrade gluten. More importantly, these enzymes could work at an acidic pH to break down gluten.
New research, focusing on our microbiome is increasing, and there is hope that enzyme therapy can be effective, and may offer relief to patients with celiac disease.
Read the full study online here.
For more information about celiac disease, visit mayoclinic.org/celiac disease.
Dr. Murray is a gastroenterologist and celiac disease expert at Mayo Clinic.